Contact Us

Biomedical Data Curation Services

BROADEN YOUR PERSPECTIVE
OF THE DATA LANDSCAPE

Excelra’s Advantage

Excelra has a team of over 500 trained data curators, each a subject matter expert, which can expand your vision of the data landscape, providing chemical, biological, or medical data, and supporting you across the full drug discovery life cycle. Our curators scour the scientific landscape for structure-activity relationships, biomarkers, clinical trial outcomes, and more. With all curations being performed manually and subject to a three-tiered, QMS-ISO certified quality control process, you can have confidence in the data we curate.

Chemical

Biological

Medical

Industrial

Turn Information into Insights

Data itself is not the goal. To facilitate your understanding of data gathered from a wide array of disparate sources, our experts structure and normalize the data using standard ontologies with a degree of consistency and accuracy that automated data harvesting methods have not yet proven capable of. We can create data sets designed for harmonization with your in-house data and compatibility with your systems, delivering data in a wide and customizable range of readily usable structures and convenient formats.

Learn more about how Excelra’s custom chemistry annotations can empower your drug design and discovery.

Here you go

See how Excelra’s clinical trial outcomes data curation unlock insights from clinical trial literature to power data driven insights

Read more

Realize Your Eureka Moment

You have questions, and you want answers that are clear and understandable. That is why Excelra does not stop at simply compiling data. We provide clear visualizations and meaningful analyses to empower your scientific judgment. When you want more interactivity with your data sets, we build dynamic dashboards to allow you to dive into your data sets to mine additional insights.

Turn Answers into Action

What we ultimately aim to provide you with is the realization of what needs to be done to drive your drug development program forward. Taking that action, however, is something you need to do yourself.

Start with one step towards empowering yourself with richer information, clearer understanding, and more accurate answers. Contact Excelra today.

Our Customized Solutions Include

Chemistry

Concept annotation and indexing

Compound-target-indication profiling

SAR & reaction data curation

Drug label, safety, and toxicity data excerption

Custom report generation for targets & indications

Biology

Actionable mutations for targeted therapy

Clinical genome variant interpretation & reporting

Gene set enrichment analysis & pathway analysis

Gene & Biological process annotation-ontology mapping

Phenotype reporting-outcome mapping

Multi-omics data integration & analysis

Clinical

Text mining & analysis of clinical trial data

Off-label use of approved drugs

Indication-specific and/or drug-specific summary level databases

Model-Based Meta-Analysis (MBMA)

Mining and harmonizing heterogeneous real-world datasets

Autoimmune

Ankylosing Spondylitis

Inflammatory Bowel Disease (IBD)

Rheumatoid Arthritis (RA)

Atopic dermatitis

Lupus nephritis (SLN)

Sjogren’s syndrome

Axial spondyloarthritis

Multiple Sclerosis

Systemic Lupus Erythematosus (SLE)

Gout

Psoriasis + psoriatic arthritis (PsO/PsA)

Cardiovascular

Acute Coronary Syndrome (ACS)

Pulmonary arterial hypertension (PAH)

Anemia

Sickle cell disease (SCD)

Heart failure

Venous Thromboembolism (VTE)

Hypertension

Ventricular tachycardia

Genitourinary

Benign prostatic hyperplasia (BPH)

Kidney transplant rejection

Chronic kidney disease

Overactive bladder

Cystitis

Prostatitis

Endometriosis

Infections

Antibacterial gram negative infection

Resistant infection

Clostridium difficile

HCV

HIV

Metabolic

Diabetes

Frailty

NAFLD

Obesity

Oncology

AML

Bladder cancer

Colorectal cancer

Hepatocellular carcinoma

Lymphoma

Nasopharyngeal carcinoma

Renal cell cancer

Pancreatic cancer

Breast cancer

Angiogenesis

Gastric cancer

Hodgkin’s lymphoma

Metastatic nasopharyngeal carcinoma

Non-Hodgkin’s lymphoma

PD1 inhibitor

Sarcoma

Antibody drug conjugate safety (ADCS)

Cancer PK parameters-Carboplatin

Glioblastoma

Immune related AE’s

Multiple myeloma

NSCLC

Solid tumours

Prostate cancer

Biliary tract cancer

Cancer PK parameters-Paclitaxel

Head & Neck squamous cell carcinoma

Immuno-oncology

Myelodysplastic syndrome

Ovarian cancer

Uterine fibroma

Refractory AML

Ophthalmology

Age related macular degeneration

Diabetic macular edema

Dry Eye Syndrome

Glaucoma

Pain and Inflammation

Fibromyalgia

Neuropain

OA Pain

Sarcoidosis

Respiratory

Asthma

COPD

Others

Bone disorder: Osteoporosis

Contraceptives

Women’s Health

Lymphocyte count

Cachexia

Dermatology: Acne vulgaris

Sarcopenia

Crohn’s mucosal healing

Dupuytren’s Disease

Stem cell

Crohn’s – Fistulizing Disease

Liver Fibrosis

Tuberculosis

Ready for the Next Step?

Learn more about what harmonized and actionable biomedical data can do for your drug discovery initiatives.